Abstract
Background:
Chronic kidney disease (CKD) is characterized by overactivation of the sympathetic nervous system (SNS) that leads to increased cardiovascular disease risk. This study was conducted to evaluate the effects of Mindfulness-Based Stress Reduction (MBSR) on SNS activity in CKD patients.
Method:
Participants with CKD stages III-IV were randomized to the 8-week MBSR program or Health Enhancement Program (HEP; a structurally parallel, active control group). Intraneural measures of SNS activity directed to muscle (MSNA) via microneurography was recorded at rest and during stress maneuvers (mental arithmetic, handgrip exercise and cold pressor test). Data analyses were performed based on the intent-to-treat principle.
Results:
29 participants (64 ±9 years; 86% males) completed the intervention with 17 in MBSR and 12 in HEP. There was a significant Group (MBSR vs. HEP) by Time (baseline vs. post-intervention) interaction in MSNA reactivity to mental stress (p=0.029), with a significant reduction in the mean ΔMSNA over 3 minutes of mental arithmetic at post-intervention (10.3 ± 4.2 to 5.9 ± 5.6 bursts/min, p<0.001; (Hedges’g = −0.858, 95% CI [−1.578, −0.167]), while no change was observed within the HEP group (p=0.818). Reduced ΔMSNA during handgrip exercise was also observed, while ΔMSNA during the cold pressor test and resting MSNA remained unchanged in both groups from baseline to post-intervention.
Conclusions:
In this randomized controlled trial, patients with CKD had a reduction of sympathetic reactivity during mental stress and static handgrip exercise following 8-weeks of MBSR but not after HEP. Our findings demonstrate that mindfulness training is feasible and may have clinically beneficial effects on autonomic function in CKD.
Trial Registration.
Funding.
NIH R01HL135183; R61AT10457; KL2TR002381; VA Merit I01CX001065.
Keywords: Mindfulness-Based Stress Reduction, Sympathetic Activity, Chronic Kidney Disease
Graphical Abstract

Patients with chronic kidney disease (CKD) stages III-IV were randomized to the 8-week Mindfulness-Based Stress Reduction (MBSR, n=17) program or Health Enhancement Program (HEP; a structurally parallel, active control group, n=12). Muscle sympathetic nerve activity (MSNA) via microneurography was assessed during 3 minutes of mental arithmetic stress at baseline and post-intervention. A reduction of ΔMSNA reactivity to mental stress was observed following 8 weeks of MBSR but not after HEP. This study’s results suggest the feasibility and clinical benefits of MSBR on autonomic function in CKD.
Introduction
Chronic kidney disease (CKD) affects more than 35 million individuals in the United States and is associated with a significantly elevated risk of cardiovascular (CV) disease and mortality by 5-15 fold (Go et al., 2004; Herzog et al., 2011). A primary contributor to heightened CV risk among patients with CKD is the persistent elevation of sympathetic nervous system (SNS) activity (Klein et al., 2003; Neumann et al., 2004; Grassi et al., 2011). Even modest declines in kidney function are associated with substantial increases in both resting SNS activity as well as SNS reactivity that are independently associated with adverse CV events (Neumann et al., 2004; Grassi et al., 2011). Clinical tools to combat SNS overactivation are limited to sympatholytic medications such as beta-blockers, alpha-blockers, and central alpha agonists. However, the use of sympatholytic medications in CKD is clinically limited (Badve et al., 2011; Tomiyama & Yamashina, 2014) due to adverse side effects (Vonend et al., 2003; Bakris et al., 2004; Hundemer et al., 2021) and inferior efficacy in CV risk reduction compared to alternative antihypertensive agents (Bakris et al., 2004; James et al., 2014; Whelton et al., 2018). Therefore, there is a critical need to develop novel therapeutic approaches to safely and effectively counter SNS overactivity to improve clinical outcomes in CKD and other high-risk patient populations characterized by SNS overactivation.
Mindfulness meditation may be one such novel nonpharmacologic strategy to lower SNS activity in individuals with CKD. In particular, mindfulness-based stress reduction (MBSR) is an 8-week structured mindfulness meditation training program that has been extensively studied and has demonstrated beneficial effects on CV outcomes in patient populations (Lengacher et al., 2012; Lakhan & Schofield, 2013; Lengacher et al., 2014). Specifically, some, although not all, studies have shown that MBSR lowers clinic and ambulatory blood pressure (BP) (Barnes et al., 2008; Manikonda et al., 2008; Goldstein et al., 2012; Younge et al., 2015; Scott-Sheldon et al., 2020), and attenuates psychological (Hoge et al., 2013; Creswell et al., 2014) and physiological reactivity to stress (Nyklicek et al., 2013; Hoge et al., 2018; Lindsay et al., 2018; Dutcher et al., 2021). Although the mechanisms underlying the cardioprotective mechanisms of MBSR remain unknown, indirect evidence suggests that MBSR may lower BP by modulating autonomic nervous system activity, particularly by lowering SNS activity (Shapiro et al., 2006; Creswell & Lindsay, 2014; Loucks et al., 2015). Earlier investigations using indirect measures of SNS activity have shown that meditation increases low frequency and high frequency heart rate variability (Ditto et al., 2006; Nijjar et al., 2014; Wang et al., 2022) and lowers plasma norepinephrine levels (Curiati et al., 2005). In addition, our group previously measured direct, intraneural recordings of muscle sympathetic nerve activity (MSNA) via the gold-standard microneurographic technique to demonstrate the first direct evidence that a single session of mindfulness meditation acutely reduces BP and MSNA in patients with CKD (Park et al., 2014). However, there have been no prior studies testing the sustained effects of MBSR on SNS activity and reactivity using direct measures of SNS activity in humans. Therefore, we performed a randomized controlled trial to test the hypothesis that MBSR leads to sustained reductions in both resting MSNA and MSNA reactivity to stress in CKD.
Methods
Ethical Approval
This study was approved by the Emory University Institutional Review Board and the Atlanta VA Health Care System Research and Development Committee and registered with clinicaltrials.gov (NCT 04099992). All study procedures conformed to the standards set forth by the Declaration of Helsinki.
Participants
Individuals with CKD stages III and IV (estimated glomerular filtration rate (eGFR) between 15-59 mL/min/1.73 m2), as defined by the race-free CKD-EPI equation (Inker et al., 2021), were recruited from Emory University clinics and the Atlanta VA Health Care System for participation in this study from September 2019 to Jun 2022.
Eligibility Criteria
All participants had stable renal function (no greater than a decline of eGFR of 1cc/min/1.73m2 per month over the prior 3 months). Exclusion criteria included uncontrolled hypertension (BP>160/90mmHg), vascular disease, use of clonidine, clinical evidence of heart failure or active heart disease determined by history, electrocardiogram (ECG) or echocardiogram, ongoing illicit drug use, alcohol use > 2 drinks/day within the past 12 months, diabetic neuropathy, severe anemia (hemoglobin <10mg/dL), and pregnancy or plans to become pregnant. Individuals with prior experience in mindfulness or meditation were excluded from the study.
Study Design and Randomization
This was a single-site, parallel-group, randomized controlled clinical trial. Participants were allocated to MBSR group or a control Health-Enhancement Program (HEP) group in a 3:2 ratio using a computer-generated sequence stratified by stage of CKD (Stage IIIA, IIIB, and IV). While the nature of the interventions did not allow for masking of the MBSR and HEP instructors and participants, all investigators and assessors were masked to study identifiers or group assignment during data analysis. After obtaining written informed consent, baseline measurements and a basic metabolic panel were obtained. All measurements were obtained in a quiet, temperate (21°C) environment, after abstaining from food, caffeine, smoking, and alcohol for at least 12 h, and exercise for at least 24 h. After baseline assessments, participants were randomly assigned to one of two interventions; MBSR and HEP. At the end of the trial, baseline measurements were repeated under identical conditions within 2 weeks following the completion of the final session. Participants were instructed not to change medication regimens, dietary habits, or physical activity levels for the duration of the study.
Study Interventions
Both interventions followed detailed manuals and were administered to small groups (4-6 participants) for 2.5 hours, once per week for eight consecutive weeks. Weekly group sessions as well as a half-day retreat were administered using Zoom© video conferencing. In addition to weekly attendance, participants were assigned 45-minutes of homework 6 days per week.
MBSR intervention
The MBSR intervention was comprised of 8 weeks of 2.5 h sessions held once per week. An additional one-day “retreat” was also required for participants to attend between weeks 7 and 8. A single, fully-certified teacher (M.D.) who had completed the University of Massachusetts MBSR professional training program with more than 15 years of mindfulness practice and teaching experience delivered the formalized program curriculum to participants.
The formal MBSR program focuses on mindfulness by increasing awareness of thoughts, feelings, and sensations from moment to moment, and to more skillfully respond (rather than automatically react) to stressors. Each of the eight weekly sessions includes psychoeducation about mindfulness and stress (including a discussion of habitual behavioral and physiological reactions to stress, and learning to more purposely respond rather than react); experiential mindfulness practice, and a discussion of participants’ experiences with mindfulness practice. Participants learn formal mindfulness practices (e.g., sitting meditation, yoga, body scan, walking meditation, body scan meditation) as well as more informal mindfulness activities such as awareness of breath, thoughts, or emotions, and mindfulness of daily life activities (e.g., eating, breathing, washing dishes). They were encouraged to practice mindfulness in their daily lives. Participants received MP4 downloads on an electronic tablet with guided mindfulness meditation practices, a home practice manual, and weekly handouts with each week’s formal and informal practice assignments. Participants were asked to perform daily home practice of 40-45 minutes of recorded practice and keep a written record of their practice times. A makeup class on a different day was available if a participant missed a class. The half-day retreat session between weeks 7 and 8 sought to further integrate acquired skills and involved guided meditation practice and reflection.
HEP Intervention
An 8-week HEP, a non-meditation intervention was administered as the gold-standard control intervention for MBSR (MacCoon et al., 2012; Eisendrath et al., 2014; Eisendrath et al., 2016). HEP is designed to provide a structurally parallel, active control intervention to MBSR within the same group-based environment, matching for group support, facilitator attention, intervention duration, time spent on at-home practice while omitting any components of mindfulness. The original HEP manual had been developed for use in a non-clinical sample as a control condition for MBSR (MacCoon et al., 2012). Specifically, HEP consists of music therapy, nutritional education, posture and balance movements, walking and stretching instructed by a health educator (a registered dietician) in a group setting for 8 weekly 2.5-hour sessions. Work with all practices with group discussion and exercises during an all-day match the all-day retreat in MBSR. Participants received MP4 downloads on an electronic tablet with recordings of health education topics, a home listening manual, and weekly handouts with each week’s listening assignments, and were asked to listen to these MP4 recordings daily for 40-45 minutes and log their daily adherence. HEP was administered by a clinician with health education experience.
Outcomes and Measurements
The primary outcomes were sympathetic activity quantified as resting MSNA and MSNA reactivity to acute stressors. Secondary outcomes included resting BP and BP reactivity to acute stressors.
Muscle Sympathetic Nerve Activity and Beat-to-Beat Blood Pressure
Multiunit postganglionic MSNA was recorded directly from the peroneal nerve by microneurography, as previously described (Wallin & Fagius, 1988). Participants were placed in a supine position, and the leg was positioned for microneurography. A tungsten microelectrode (tip diameter 5–15 μm, 2.0 ± 0.4 MΩ impedance) (Bioengineering, University of Iowa and FHC, Bowdoin, ME) was inserted into the nerve, and a reference microelectrode was inserted subcutaneously 1–2 cm from the recording electrode. The signals were amplified (total gain: 50,000–100,000), filtered (700-2,000 Hz), rectified, and integrated (time constant 0.1 s) to obtain a mean voltage display of sympathetic nerve activity (Nerve Traffic Analyzer, model 662C-4, University of Iowa, Bioengineering) that was recorded by the LabChart 7 Program (PowerLab 16sp, ADInstruments). Continuous ECG was recorded simultaneously with the neurogram using a bioamp system. Beat-to-beat arterial BP was measured concomitantly using a noninvasive monitoring device that detects digital blood flow via finger cuffs and translates blood flow oscillations into continuous pulse pressure waveforms and beat-to-beat values of BP (Finometer, Finapres Medical Systems, Amsterdam, The Netherlands and CNAP™, CNSystems Medizintechnik, Graz, Austria) (Jeleazcov et al., 2010). Absolute values of BP were internally calibrated using a concomitant upper arm BP reading and were calibrated at the start and every 15 min throughout the study. The tungsten microelectrode was manipulated to obtain a satisfactory nerve recording that met previously established criteria (Mano et al., 2006). After 10 min of rest, BP, ECG, and MSNA were recorded continuously for 10 min. After 10 minutes of rest, MSNA, beat-to-beat BP, heart rates (HR) and ECG were continuously measured throughout the stress protocols that include mental arithmetic (3 min), handgrip exercise (3 min) and cold pressor test (CPT, 1min), separated by 15 min of rest and followed by 5 minutes of recovery. Detailed stress maneuver protocols are described below.
For MSNA data analysis, MSNA and ECG data were exported from the LabChart data acquisition system to WinCPRS (Absolute Aliens, Turku, Finland) for analysis. R-waves were detected and marked from the continuous ECG recording. MSNA bursts were automatically detected by the program using the following criteria: 3:1 burst-to-noise ratio within a 0.5-s search window, with an average latency in burst occurrence of 1.2–1.4 s from the previous R-wave. After automatic detection, the ECG and MSNA neurograms were visually inspected for accuracy of detection. MSNA was expressed as burst frequency (bursts/min) and burst incidence (bursts/100 heartbeats).
The spontaneous sympathetic baroreflex sensitivity (sBRS; Ensemble, Elucimed, Wellington, New Zealand) and the cardiac baroreflex sensitivity (cBRS; CardioSeries v2.4) were quantified. The spontaneous sBRS was quantified using the method originally described by Kienbaum et al (2001). Briefly, sBRS was measured by shifting the MSNA nerve tracing (~1.2–1.4 s) to account for conduction delay, binning diastolic BP into 3-mmHg increments, and plotting MSNA burst incidence against diastolic BP. The slope of the linear regression analysis (r > 0.7) provided the sBRS for each participant (Sabino-Carvalho et al., 2024). cBRS was assessed using the sequence technique which analyzes progressive changes in systolic BP followed by corresponding changes in RR intervals over three or more heartbeats, as previously described (Sabino-Carvalho et al., 2023). The slope of the SBP-RR interval relationship for all sequences was identified using linear regression analysis (R2 ≥ 0.85) and the total cBRS sequences was detected, analyzed and reported.
Resting heart rate variability (HRV) was determined in accordance with the guidelines of the Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) and was quantified in the time domain as root mean square of the successive differences (RMSSD) using a 5-min segment at baseline.
Resting Blood Pressure
Baseline resting BP was measured after 5 min of rest in a seated position with the arm supported at heart level using an appropriately sized cuff per American College of Cardiology/American Heart Association (ACC/AHA) guidelines (Whelton et al., 2018) using an automated device (Omron, HEM-907XL, Omron Healthcare, Kyoto, Japan). Measurements were taken three times, with each reading separated by a one-minute interval. Mean arterial blood pressure (MAP) was calculated as 2/3 diastolic BP (DBP) + 1/3 systolic BP (SBP).
Intervention Satisfaction
Participants in both groups completed the 8-item Client Satisfaction Questionnaire (CSQ-8) to assess intervention satisfaction (Attkisson & Zwick, 1982) at post-intervention.
Stress Maneuvers
Mental Arithmetic.
Participants were asked to serially subtract a one- or two-digit number from a three- or four-digit number and were urged to do so as quickly and accurately as possible for 3 minutes. An investigator used flash cards with a three- or four-digit number and was urged by two additional study team members in white coats to answer ‘faster’ and ‘get it right’. At the end of mental stress, participants were asked to rate their perceived stress during the mental math trial using a standard five-point scale, ranging from 0 (no stress) to 4 (severe stress). This test is shown to induce mental stress and increase MSNA (Fonkoue et al., 2020) (Park et al., 2017).
Static Handgrip (SHG).
Moderate intensity SHG was performed by squeezing the hand dynamometer at 30% maximal voluntary contraction in a sustained manner for 3 min. The participant was instructed to avoid inadvertent Valsalva and to maintain normal breathing patterns. Moderate SHG elicits an increase in MSNA (Mark et al., 1985) by activating the exercise pressor reflex and central command.
Cold Pressor Test (CPT).
The dominant hand was immersed up to the wrist in an ice water bath (4°C) for 1 min, which was followed by 3 min of recovery. Subjects were instructed to avoid breath holding and to stay as relaxed as possible. The participant was asked to rate the degree of pain during the maneuver on a five-point pain scale, ranging from 0 (no pain) to 4 (severe pain). CPT is a sympatho-excitatory maneuver that is known to evoke an increase in MSNA (Victor et al., 1987).
Statistics
Based on our pilot data, the group difference in MSNA change after MBSR program (vs. a control program) was estimated to be −9.7 ± 5.4 bursts/min. A minimum of 33 in total (20 in MBSR and 13 in a control group) was required to achieve >90 % power at a significance level (α) of 0.05 for the primary outcome (MSNA) after considering the expected 20% dropout rate.
Values are presented as mean ± standard deviation (SD) unless otherwise noted. Data normality was assessed by the Shapiro-Wilk test for continuous variables. Differences in participant characteristics between groups were determined using independent, 2-tailed, t-tests for continuous variables and chi-square tests for categorical variables. When normality was not met, Mann-Whitney U tests were used. The primary analyses were based on the intention-to-treat approach. Repeated ANOVA tests with Group (MBSR vs. HEP) as a between factor and Time (baseline and post-intervention) as a within factor were used to analyze the change in MSNA reactivity during 3 minutes of mental arithmetic and SHG and 1 minute of CPT. In addition, a linear mixed model (LMM) analysis was conducted with Minutes, Group and Time as fixed factors and participants as a random factor to compare the group difference in slope-of-rise in the absolute MSNA change over 3 minutes of mental arithmetic and SHG. Adjustment with potential confounding factors, including sex and the use of antihypertensive medications, was performed. Sensitivity analysis, including within-group analysis and weighting adjustments with group sample sizes, was also conducted. The within-group comparison from baseline to 8 weeks was done using 2-tailed, paired t-tests. Weights were calculated based on the sample proportions of MBSR and HEP groups relative to the intended equal allocation ratio, and weighted repeated ANOVA was conducted. Additionally, effect size values, including partial η2 and omega squared (ω2) for the interaction effect and Hedges’ g for within-group comparisons, which are conservative estimates adjusted for small and unbalanced sample sizes, were reported to quantify the magnitude of the observed effects between and within groups. An α <0.05 was considered statistically significant for all analyses. All analyses were performed using SPSS version 26.0 (IBM Corporation, Somers, NY) and R (version 4.0.2, R Foundation for Statistical Computing, Vienna, Austria).
Results
Participants and Intervention Adherence
A total of twenty-nine participants who completed the study intervention were included in this study (Figure 1). No significant differences in baseline demographics, comorbid conditions, medication use or clinical characteristics were observed between the MBSR and HEP groups. Intervention adherence measured by attendance of intervention group sessions, retreats and time spent on total home practice was high in both groups and comparable. CSQ-8 score indicated that participants in both groups were generally satisfied with the intervention (Table 1).
Figure 1.

CONSORT diagram. The diagram depicts patient flow through the randomized clinical trial.
MBSR: Mindfulness-Based Stress Reduction, HEP: Health Enhancement Program, ITT: Intent-to-Treat.
Table 1.
Participant Characteristics and Intervention Adherence
| Characteristics | MBSR (n=17) | HEP (n=12) | P-value# |
|---|---|---|---|
| Age (yr) | 64.1 ± 8.1 | 63.3 ± 10.3 | 0.834 |
| Sex (male, %) | 15 (88%) | 10 (83%) | 0.556 |
| Race | |||
| Black | 10 (59%) | 10 (83%) | 0.160 |
| White | 7 (41%) | 2 (17%) | |
| Height (cm) | 176 ± 8 | 177 ± 11 | 0.770 |
| Weight (kg) | 102 ± 22 | 94 ± 17 | 0.322 |
| BMI (kg/m2) | 32.9 ± 6.2 | 30.1 ± 4.8 | 0.202 |
| Smokers (n,%) | 8 (47%) | 7 (58%) | 0.729 |
| Hypertension (n,%) | 14 (82%) | 11 (92%) | 0.474 |
| Diabetes (n,%) | 7 (41%) | 7 (58%) | 0.362 |
| Antihypertensive medications (n,%) | |||
| ACEI/ARB | 13 (76%) | 9 (75%) | 0.927 |
| CCB | 9 (53%) | 7 (58%) | 0.774 |
| Diuretics | 9 (53%) | 5 (42%) | 0.550 |
| β-blockers | 4 (24%) | 7 (58%) | 0.057 |
| α-blockers | 5 (29%) | 2 (17%) | 0.430 |
| Hydralazine | 2 (12%) | 0 (0%) | 0.218 |
| Statin (n,%) | 10 (59%) | 7 (58%) | 0.979 |
| eGFR (ml·min−1·1.73 m−2) | 40.7 ± 12.3 | 46.0 ± 7.4 | 0.205 |
|
| |||
| Intervention Adherence and Satisfaction | |||
| Class Attendance (%) | 95 ± 10 | 94 ± 11 | 0960 |
| Home Practice (%) | 78 ± 23 | 85 ± 21 | 0.610 |
| Home Practice (hour) | 34 ± 19 | 43 ± 23 | 0.212 |
| Retreat Attendance | 14/17 | 8/12 | 0.349 |
| Satisfaction | 28 ± 4 (86 ± 13%) | 30 ± 2 (95 ± 6 %) | 0.066 |
Continuous values are expressed as means ± standard deviation.
BMI: Body Mass Index, ACEI: Angiotensin Converting Enzyme Inhibitors, ARB: Angiotensin Receptor Blocker CCB: Calcium Channel Blocker, eGFR: Estimated Glomerular Filtration Rate.
indicates p-values for group comparisons by independent t-tests or Mann-Whitney U tests for continuous variables and chi-square tests for categorical variables.
Effect of MBSR on MSNA and Hemodynamics at Rest and During Stress
Resting Outcomes.
Resting MSNA, BP, heart rate, cBRS, sBRS and RMSSD remained unchanged in both groups from pre-intervention baseline levels to post-intervention (Table 2).
Table 2.
Effects of MBSR vs. HEP Intervention on Resting and Reactivity to Mental Arithmetic, Static Handgrip and Cold Pressor Test of Cardiovascular and Sympathetic Parameters at in Patients with Chronic Kidney Disease.
| MBSR (n=17) |
HEP (n=12) |
|||||||
|---|---|---|---|---|---|---|---|---|
| Baseline | 8 weeks | Within-group P-value# | Baseline | 8 weeks | Within-group P-Value# | Between-group P-Value& | Group x Time P-value* | |
| Resting | ||||||||
| SBP (mmHg) | 122 ± 11 | 118 ±16 | 0.233 | 123 ± 12 | 121 ± 11 | 0.665 | 0.705 | 0.772 |
| DBP (mmHg) | 75 ± 8 | 71 ± 13 | 0.157 | 73 ± 12 | 72 ± 9 | 0.934 | 0.475 | 0.322 |
| MAP (mmHg) | 91 ± 8 | 86 ±14 | 0.161 | 89 ± 11 | 88 ± 8 | 0.787 | 0.715 | 0.441 |
| HR (bpm) | 72 ± 9 | 69 ±9 | 0.101 | 64 ± 7 | 66 ± 10 | 0.397 | 0.088 | 0.083 |
| MSNA (bursts/min) | 32.8 ± 7.6 | 33.8 ±8.9 | 0.382 | 38.9 ± 9.4 | 36.2 ± 8.9 | 0.193 | 0.276 | 0.096 |
| MSNA (bursts/100HB) | 53.7 ± 15.3 | 55.8 ± 17.9 | 0.395 | 61.3 ± 12.3 | 59.3 ± 12.6 | 0.632 | 0.320 | 0.372 |
| cBRS (ms/mmHg) | 6.0 ± 2.3 | 7.9 ± 4.2 | 0.058 | 9.1 ± 6.0 | 10.4 ± 6.0 | 0.329 | 0.276 | 0.210 |
| sBRS┼ (bursts/100HB/mmHg) | −1.4 ± 0.7 | −1.3 ± 0.5 | 0.630 | −1.6 ± 0.8 | −1.4 ± 0.6 | 0.632 | 0.613 | 0.372 |
| RMSSD (ms) | 34.6 ± 50.8 | 28.6 ± 23.6 | 0.904 | 31.1 ± 33.0 | 40.3 ± 37.0 | 0.701 | 0.904 | 0.210 |
| Reactivity to Mental Arithmetic | ||||||||
| Δ SBP (mmHg) | 6 ± 12 | 5 ± 6 | 0.671 | 9 ± 12 | 8 ± 7 | 0.808 | 0.526 | 0.914 |
| Δ DBP (mmHg) | 4 ± 6 | 2 ± 15 | 0.566 | 5 ± 6 | 4 ± 11 | 0.684 | 0.667 | 0.805 |
| Δ MAP (mmHg) | 5 ± 10 | 5 ± 5 | 0.841 | 8 ± 6 | 6 ± 4 | 0.527 | 0.425 | 0.787 |
| Δ HR (bpm) | 4 ± 4 | 4 ± 3 | 0.759 | 4 ± 6 | 4 ± 4 | 0.505 | 0.854 | 0.794 |
| Δ MSNA (bursts/min) | 10.3 ± 4.2 | 5.9 ± 5.6 | 0.012 | 9.3 ± 4.6 | 9.5 ± 5.1 | 0.818 | 0.554 | 0.029 |
| Δ MSNA (bursts/100HB) | 12.6 ± 8.8 | 5.7 ± 8.4 | <0.001 | 10.8 ± 9.2 | 11.8 ± 8.0 | 0.639 | 0.585 | 0.003 |
| Reactivity to SHG | ||||||||
| Δ SBP (mmHg) | 11 ± 11 | 11 ± 13 | 0.929 | 10 ± 10 | 6 ± 8 | 0.277 | 0.842 | 0.286 |
| Δ DBP (mmHg) | 7 ± 7 | 9 ± 8 | 0.451 | 8 ± 6 | 6 ± 7 | 0.529 | 0.974 | 0.318 |
| Δ MAP (mmHg) | 10 ± 9 | 10 ± 9 | 0.973 | 9 ± 8 | 7 ± 6 | 0.353 | 0.734 | 0.416 |
| Δ HR (bpm) | 5 ± 4 | 6 ± 5 | 0.543 | 6 ± 6 | 5 ± 4 | 0.832 | 0.750 | 0.623 |
| Δ MSNA (bursts/min) | 14.1 ± 6.8 | 10.1 ± 6.4 | 0.136 | 10.8 ± 7.8 | 11.9 ± 9.1 | 0.587 | 0.264 | 0.155 |
| Δ MSNA (bursts/100HB) | 16.2 ± 11.2 | 8.7 ± 10.3 | 0.045 | 9.5 ± 8.5 | 13.0 ± 12.3 | 0.253 | 0.108 | 0.029 |
| Reactivity to CPT | ||||||||
| Δ SBP (mmHg) | 7 ± 9 | 1 ± 16 | 0.089 | 11 ± 19 | 8 ± 12 | 0.559 | 0.387 | 0.641 |
| Δ DBP (mmHg) | 8 ± 4 | 8 ± 9 | 0.851 | 14 ± 13 | 13 ± 11 | 0.673 | 0.093 | 0.837 |
| Δ MAP (mmHg) | 9 ± 6 | 6 ± 12 | 0.252 | 15 ± 16 | 10 ± 9 | 0.357 | 0.242 | 0.764 |
| Δ HR (bpm) | 7 ± 4 | 6 ± 4 | 0.126 | 10 ± 10 | 11 ± 8 | 0.688 | 0.422 | 0.272 |
| Δ MSNA (bursts/min) | 13.8 ± 15.4 | 11.8 ± 5.8 | 0.600 | 20.4 ± 16.4 | 22.1 ± 8.0 | 0.658 | 0.364 | 0.514 |
| Δ MSNA (bursts/100HB) | 15.1 ± 22.1 | 13.4 ± 12.4 | 0.754 | 17.6 ± 11.8 | 23.6 ± 9.2 | 0.340 | 0.734 | 0.503 |
Values are expressed as mean ± standard deviation.
SBP: Systolic Blood Pressure, DBP: Brachial Diastolic Blood Pressure, MAP: Mean Arterial Blood Pressure, HR: Heart Rate, MSNA: Muscle Sympathetic Nervous Activity, HB: Heart Beats, cBRS: Cardiac Baroreflex Sensitivity, sBRS: Cardiac Baroreflex Sensitivity, RMSSD: Root Mean Square of Successive Differences, SHG: Static Handgrip, CPT: Cold Pressor Test.
indicates p-values for within-group comparisons over 8 weeks were tested by paired t-tests.
indicates p-values for between-group comparisons at baseline by independent t-tests or Mann-Whitney U tests.
indicates p-values for between-group comparisons on the changes over 8 weeks (Group by Time) were tested by repeated ANOVA tests.
: sBRS results were from 13 patients (n=7 in MBSR, n=6 in HEP) that met the analysis criteria, the sBRS regression r value of > 0.7.
Reactivity to Mental Arithmetic.
There was a significant Group (MBSR vs. HEP) by Time (baseline vs. post-intervention) interaction in MSNA reactivity to mental arithmetic stress over 3 minutes (p = 0.029 and 0.003; partial η2 = 0.165 and 0.281; ω2 = 0.157 and 0.268 for burst frequency and burst incidence, respectively). Specifically, the MBSR group had a significant reduction in the mean change in ΔMSNA over 3 minutes of mental arithmetic at post-intervention (Hedges’ g = −0.858, 95% CI [−1.578, −0.167] and −0.784, 95% CI [−1.49, −0.09] for MSNA burst frequency and incidence respectively), while no change was observed within the HEP group (Hedges’ g = −0.039, 95% CI [−0.76, 0.84] and 0.120, 95% CI [−0.67, 0.92] for MSNA burst frequency and incidence respectively) (Figure 2 A–B). ΔMSNA was lower at the 1st, 2nd and 3rd minute of mental arithmetic within the MBSR group at post-intervention (7.2 ± 5.1 to 2.6 ± 6.3, p=0.017; 11.3 ± 8.9 to 5.8 ± 6.9, p=0.010; 12.5 ± 8.6 to 7.8 ± 5.6, p=0.010 bursts/min respectively; 8.6 ± 6.8 to 1.1 ± 9.4, p=0.004; 13.4 ± 11.2 to 5.8 ± 10.9, p=0.005; 16.2 ± 12.7 to 8.0 ± 7.6, p=0.011 bursts/100 heartbeats respectively), while no such change was observed within the HEP group (p>0.05 for all) (Figure 3 A–D). In addition, LMM analyses revealed a significant decrease in the slope-of-rise of absolute ΔMSNA changes during 3 minutes of mental arithmetic from baseline to post-intervention within the MBSR group, but not in the HEP group (effect sizes for the group difference (MBSR vs. HEP) in the slope change (baseline to post-intervention) of ΔMSNA: −1.46 bursts/min per min; p=0.011 and −2.34 bursts/100 heartbeats per min; p=0.006). Results were similar when adjusted for sex and antihypertensive medication usage, as well as when weighted with group sample sizes (p=0.036 and 0.006 for Group by Time interaction effect on burst frequency and burst incidence, respectively). There was no significant change in the reactivity of BP and heart rate during mental arithmetic in both groups (Figure 3 E–H). The individual reactivity in MSNA, BP and heart rate over 3 minutes of mental arithmetic at baseline and post-intervention in MBSR and HEP groups are shown in Supplemental Figures 1 and 2 respectively. Perceived stress levels during mental arithmetic were comparable between baseline and post-intervention in both groups (2.2 ± 1.2 to 2.2 ± 0.9 in the MBSR and 2.5 ± 1.0 to 2.4 ± 1.3 in the HEP group, p=0.825 for the Group by Time interaction).
Figure 2.

Reactivity of Muscle Sympathetic Nervous Activity (MSNA) Burst Frequency (A) and MSNA Burst Incidence (B) averaged over 3 minutes of Mental Arithmetic from baseline (0 wk) to post-intervention (8 wk) in patients with chronic kidney disease randomized to Mindfulness-Based Stress Reduction (MBSR; N=17) versus Health Enhancement Program (HEP; N=12) groups.
Open circles (∘) depict individual values for each study participant and bar graphs depict the mean and standard deviation values at baseline and post-intervention within each group. P-values denote statistically significant differences in the change from baseline to post-intervention between groups (Group x Time interaction) by repeated ANOVA tests.
* denotes statistically significant within-group difference from baseline to post-intervention by paired t-tests.
Figure 3.

Reactivity in Muscle Sympathetic Nervous Activity (MSNA) Burst Frequency (A, B), MSNA Burst Incidence (C, D), Mean Arterial Blood Pressure (MAP) (E, F) and Heart Rate (HR) (G, H) during each minute of Mental Arithmetic from baseline (0 wk, closed circles) to post-intervention (8 wk, open circles) in patients with chronic kidney disease randomized to Mindfulness-Based Stress Reduction (MBSR; N=17) versus Health Enhancement Program (HEP; N=12) groups.
* denotes a statistically significant Time (baseline vs. post-intervention) by Minute (1st, 2nd or 3rd minute) interaction effect within the MSBR group by repeated ANOVA tests.
Reactivity to Static Handgrip Exercise.
There was a significant Group (MBSR vs. HEP) by Time (baseline vs. post-intervention) interaction in ΔMSNA burst incidence to SHG (p=0.029), with a reduced mean change in ΔMSNA burst incidence over 3 minutes of SHG following MBSR (Hedges’ g = −0.627, 95% CI [−0.084, 1.337], p=0.045), but no change within the HEP group post-intervention (p=0.253) (Table 2). There was no group difference in mean change in ΔMSNA burst frequency, ΔBP and ΔHR over 3 minutes of SHG from baseline to post-intervention in both MBSR and HEP groups (p>0.050 for both, Table 2). LMM analyses showed no significant group difference in the slope-of-rise of absolute ΔMSNA during 3 minutes of SHG from baseline to post-intervention between the MBSR and HEP groups (effect sizes for the group difference for ΔMSNA: −0.67 bursts/min per min; p = 0.360 and −1.57 bursts/100 heartbeats per min; p = 0.133).
Reactivity to Cold Pressor Test.
ΔMSNA, ΔBP and ΔHR to CPT remained unchanged from baseline to post-intervention in both MBSR and HEP groups (Table 2). Perceived pain levels during CPT were comparable between baseline and post-intervention in both groups (2.3 ± 1.3 to 2.0 ± 1.4 in the MBSR and 3.5 ± 0.7 to 2.9 ± 1.0 in the HEP group, p=0.416 for the Group by Time interaction).
The Impact of Baseline MSNA Reactivity on MBSR-Induced Changes
We further examined the linear association of baseline levels of MSNA reactivity during mental arithmetic with MBSR-induced changes in MSNA reactivity within the MBSR group. The magnitude of change in MSNA reactivity was inversely associated with baseline MSNA reactivity (p<0.001, Figure 4A, C) in the MBSR group, while no significant association was found within the HEP group (p>0.050; Figure 4B, D).
Figure 4.

Association between Reactivity in Muscle Sympathetic Nervous activity (MSNA) Burst Frequency and MSNA Burst Incidence during Mental Arithmetic at Baseline (0 wk) and the Change (post-intervention; 8 wk – baseline; 0 wk) in MBSR (A, C respectively, n=17) and in the HEP Group (B, D respectively, n=12) by Pearson correlation tests.
Closed circles (•) depict individual values for each study participant in the MBSR group, while open circles (∘) depict individual values for each study participant in the HEP group.
Discussion
We conducted a randomized controlled trial testing the efficacy of MBSR in lowering SNS overactivity in patients with CKD. By using direct intraneural recordings of SNS activity directed to the muscle via microneurography, we demonstrate a significant reduction in MSNA reactivity during acute mental and exercise stress in CKD patients who were randomized to 8 weeks of MBSR compared to the HEP control intervention. The MBSR intervention was well-accepted with high adherence rates to classes and practice homework, and our results suggest that MBSR may be a feasible adjunct intervention to improve CV risk by modulating autonomic balance in CKD.
MBSR is the most extensively studied meditation intervention in the US, with confirmed psychological and physiological health benefits including improved CV disease risk across different patient populations (Lengacher et al., 2012; Lakhan & Schofield, 2013; Lengacher et al., 2014; Younge et al., 2015; Scott-Sheldon et al., 2020). Mindfulness-based interventions are hypothesized to improve CV health by promoting effective self-emotion regulation through non-judgmental present-moment awareness and a shift in stress appraisal, ultimately reducing the stress-reactivity response (Shapiro et al., 2006; Garland et al., 2015; Loucks et al., 2015). These improvements in coping skills and psychological functioning may be coupled with the normalization of physiological functioning, such as the autonomic nervous system, potentially leading to improved CV outcomes (Creswell & Lindsay, 2014). Despite this concept that autonomic regulation during stress may underlie the CV health benefits of MBSR, limited research has investigated this area, with existing data primarily relying on indirect markers of autonomic function (Ditto et al., 2006; Nijjar et al., 2014; Wang et al., 2022) such as heart rate variability and plasma norepinephrine (Curiati et al., 2005), and largely focusing on resting-state activity. We now provide the first evidence that MBSR may modulate SNS response to acute mental stress in CKD, a patient population at increased CV risk by virtue of chronic SNS overactivation. Our results align with previous evidence demonstrating that MBSR has favorable effects on stress responses on objectively measured stress biomarkers (Nyklicek et al., 2013; Hoge et al., 2018; Lindsay et al., 2018) as well as self-reported stress scales (Hoge et al., 2013; Creswell et al., 2014). Prior work has shown that mindfulness-based interventions may attenuate increases in BP (Nyklicek et al., 2013; Lindsay et al., 2018), neurohormonal (cortisol, adrenocorticotropic hormone) and inflammatory (IL-6, TNF-a) reactivity (Hoge et al., 2018), perceived stress levels (Hoge et al., 2013; Creswell et al., 2014) and functional magnetic resonance imaging-based neural reactivity (Goldin & Gross, 2010; Dutcher et al., 2021) during stressful stimuli. Given heightened physiological responses to stressors have been linked to an increased risk of CV diseases and mortality (Chida & Steptoe, 2010; Weiss et al., 2010; Schultz et al., 2013), our results demonstrating MBSR-driven reductions in SNS stress reactivity have important clinical implications for CV risk management in CKD.
Our data also demonstrate that participants who initially displayed an augmented MSNA response to stress exhibited a more substantial reduction in MSNA reactivity following the MBSR intervention. This pattern of intervention response linked to the initial stress profile was specific to MBSR and not observed within the HEP group; thus, it is unlikely that these findings can be explained by regression toward the mean. These findings are in line with previous reports demonstrating a greater degree of BP reduction with MBSR in those with elevated levels of BP initially (Loucks et al., 2019; Lee et al., 2020). Therefore, our findings suggest that the expected benefits of MBSR on autonomic stress reactivity may vary depending on an individual’s initial stress response patterns, emphasizing the importance of tailored interventions to maximize the clinical utility of MBSR for optimal CV risk management in CKD.
Contrary to our hypothesis, decreased MSNA reactivity was not significantly associated with changes in BP reactivity, nor did resting BP and MSNA change significantly following the MBSR intervention in the present study. Many (Younge et al., 2015; Scott-Sheldon et al., 2020), but not all meta-analyses (Abbott et al., 2014) have demonstrated clinically significant reductions in BP as well as task-driven BP responses after participating in an MBSR intervention in individuals with CV disease. Our previous investigation showed BP and MSNA were acutely attenuated during a mindfulness meditation session that was sustained during the immediate recovery period in CKD patients (Park et al., 2014). However, in the present study, resting BP and MSNA were not altered after the completion of 8 weeks of MBSR, although the time frame and study design were not comparable between the previous and the current studies (i.e., the acute response to 14 minutes of mindfulness meditation vs. the changes over 8 weeks on resting MSNA and responses to a stressor). It is possible that more comprehensive or prolonged practice is needed for sustained improvements in resting MSNA, with downstream improvements in BP profiles in CKD. Alternatively, long-term change in BP stress reactivity may be more closely tied to peripheral vascular (i.e., adrenergic receptor sensitivity) and autonomic feedback (i.e., baroreflex sensitivity) mechanisms rather than changes in central SNS output, or due to other non-adrenergic mechanisms (i.e., inflammatory or renin-angiotensin-aldosterone system (RAAS) pathways). Furthermore, differences in sympathetic transduction could also alter the relationship between MSNA and BP, and should be further investigated in future studies. It should also be noted that the majority of study participants were on anti-hypertensive medications, including RAAS inhibitors (76%), calcium-channel blockers (55%) and beta-blockers (38%), which might have modulated the transduction of SNS activation on peripheral vasculature during an acute stressor to some extent.
We observed discrepant results in MSNA reactivity during different types of stressors following MBSR in CKD. While we observed significant reductions in ΔMSNA burst frequency and incidence during mental arithmetic and a reduction in ΔMSNA burst incidence during static handgrip exercise after MBSR, no significant change in MSNA reactivity was observed during pain stress by cold pressor test. Although the mechanisms underlying these discrepant results are unclear, these differences in autonomic stress reactivity after MBSR may be attributed to the unique physiological mechanisms underlying each stressor. Mental stress increases SNS activity primarily through central neural pathways involving higher brain centers such as the prefrontal cortex, amygdala, and hippocampus (Herman et al., 2003; Ulrich-Lai & Herman, 2009). On the other hand, physical exercise involves a multifaceted interplay of peripheral and central mechanisms that increase SNS activity (Gallagher et al., 2006; Smith et al., 2006). This includes input from metabo- and mechano-receptors in skeletal muscles, baroreflex receptors on the carotid arteries, aortic arch, and pulmonary vessels, and central command signals, all working together to regulate SNS activity (Gallagher et al., 2006; Smith et al., 2006). The cold pressor test primarily increases SNS via nociceptors (pain receptors) on the skin (Burton et al., 2016). These peripheral factors are closely tied to the physiological demands posed by exercise and pain and play a significant role in determining autonomic responses. Mindfulness practice aims to promote emotional self-regulation and reduce stress appraisal, potentially achieved through enhanced regulation of central neural signals. Previous evidence has demonstrated that mindfulness training can reduce CV responses during mental stress tasks (Nyklicek et al., 2013; Lindsay et al., 2018), and induce positive changes in brain regions responsible for processing stress neural signals (Creswell et al., 2007; Modinos et al., 2010; Holzel et al., 2013; Taren et al., 2015). In addition, previous work has shown that CKD patients have exaggerated exercise pressor reflex leading to augmented blood pressure reactivity during handgrip exercise (Park et al., 2013). Therefore, MBSR may have greater effects on SNS activation during mental stress and physical stress, driven by both central and peripheral mechanisms, while its impact on pain stress, mediated largely by peripheral nociceptive pathways, may be less pronounced due to the reduced involvement of central autonomic pathways (Gallagher et al., 2006; Smith et al., 2006; Burton et al., 2016). Additionally, baroreflex sensitivity and its resetting during stress may modulate SNS activity differently across various stressors and contribute to the variability in autonomic responses (Dampney, 2017). Although we assessed resting BRS data, these measures might not fully reflect baroreflex function during distinct stress tasks. Our study was not designed to reveal the different mechanisms and mediating variables behind this dissociation, which may be worthy of further exploration.
Limitations
The majority of participants were Black males which may limit the generalizability of study results to females and other races. Antihypertensive medications such as angiotensin receptor blockers are known to impact sympathetic activity (Ohlstein et al., 1997), and therefore, may have confounded results, although no difference in medication usage was found between groups at baseline, and the primary results remained the same when adjusted for medication use. Furthermore, participants maintained a stable medication regimen throughout the study period. Therefore, MBSR-induced changes in MSNA stress reactivity are likely to represent true intervention effects, and the results of this study can be applicable to the general medicated CKD patients. MSNA burst amplitude (i.e., MSNA total activity) was not quantified due to shifts in baseline during some of the stress maneuvers. The intervention sessions were administered virtually due to COVID-19 restrictions. However, besides the virtual platform, MBSR was administered per standard protocol by a certified MBSR trainer. The nature of the interventions did not allow for masking of the MBSR and HEP instructors and participants. However, analyses of all physiologic data were made in a masked fashion without the investigators’ knowledge of group assignment. In addition, the active control intervention, HEP, was administered in parallel and matched for group setting, instructor attention, intervention duration, time spent on at-home practice while omitting any components of mindfulness. We acknowledge the unequal group sizes in this early phase RCT that prioritized randomization to the active intervention group. A sensitivity analysis demonstrated consistent results, and the effect size measures that are adjusted for small and unbalanced groups (Lakens, 2013; Kroes & Finley, 2023) indicated moderate to large intervention effects in the primary outcomes, supporting the reliability of the observed intervention impact.
Conclusion
In this randomized controlled trial, we evaluated the effects of MBSR on SNS activity and reactivity in CKD and demonstrated a beneficial effect of MBSR on sympathetic reactivity during mental stress and static handgrip exercise. We also observed greater reductions in MSNA reactivity in participants with higher MSNA reactivity at baseline suggesting that MBSR may have greater beneficial effects in patients with higher sympathetic reactivity to stress. Our results highlight the therapeutic potential of MBSR in ameliorating mental stress-induced SNS overactivation in CKD.
Supplementary Material
Supplemental Figure 1. Mean and Individual Reactivity in Muscle Sympathetic Nervous Activity (MSNA) Burst Frequency (A, B), MSNA Burst Incidence (C, D), Mean Arterial Blood Pressure (MAP) (E, F) and Heart Rate (HR) (G, H) during each minute of Mental Arithmetic from baseline (0 wk) to post-intervention (8 wk) in patients with chronic kidney disease randomized to Mindfulness-Based Stress Reduction (MBSR; N=17). Closed circles represent the means and standard deviations at the Minute.
P-values represent significant levels of within-group comparisons on the changes over 3 minutes by repeated ANOVA tests.
* denotes statistically significant within-group difference from Minute 0 by LSD post-hoc tests.
# denotes statistically significant within-group difference from Minute 1 by LSD post-hoc tests.
Supplemental Figure 2. Mean and Individual Reactivity in Muscle Sympathetic Nervous Activity (MSNA) Burst Frequency (A, B), MSNA Burst Incidence (C, D), Mean Arterial Blood Pressure (MAP) (E, F) and Heart Rate (HR) (G, H) during each minute of Mental Arithmetic from baseline (0 wk) to post-intervention (8 wk) in patients with chronic kidney disease randomized to Health Enhancement Program (HEP; N=12). Closed circles represent the means and standard deviations at the Minute.
P-values represent significant levels of within-group comparisons on the changes over 3 minutes by repeated ANOVA tests.
* denotes statistically significant within-group difference from Minute 0 by LSD post-hoc tests.
# denotes statistically significant within-group difference from Minute 1 by LSD post-hoc tests.
Key Points.
Question:
Does Mindfulness-Based Stress Reduction (MBSR) program reduce sympathetic activity in patients with chronic kidney disease (CKD)?
Finding:
In this randomized controlled trial including 29 patients with CKD, 8 weeks of MBSR decreases sympathetic reactivity to mental stress compared to the control Health Enhancement Program (HEP).
Meaning:
These finding suggest that mindfulness training may have clinically beneficial effects on autonomic function in CKD.
Acknowledgments
This study was funded by NIH R01HL135183; NIH R61AT10457; NIH KL2TR002381; VA Merit I01CX001065. The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Footnotes
Conflict of Interest Disclosures: None reported.
Data Availability Statement
All data supporting the results of the present study are reported in the manuscript.
References
- (1996). Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 93, 1043–1065. [PubMed] [Google Scholar]
- Abbott RA, Whear R, Rodgers LR, Bethel A, Thompson Coon J, Kuyken W, Stein K & Dickens C. (2014). Effectiveness of mindfulness-based stress reduction and mindfulness based cognitive therapy in vascular disease: A systematic review and meta-analysis of randomised controlled trials. J Psychosom Res 76, 341–351. [DOI] [PubMed] [Google Scholar]
- Attkisson CC & Zwick R. (1982). The client satisfaction questionnaire. Psychometric properties and correlations with service utilization and psychotherapy outcome. Eval Program Plann 5, 233–237. [DOI] [PubMed] [Google Scholar]
- Badve SV, Roberts MA, Hawley CM, Cass A, Garg AX, Krum H, Tonkin A & Perkovic V. (2011). Effects of beta-adrenergic antagonists in patients with chronic kidney disease: a systematic review and meta-analysis. J Am Coll Cardiol 58, 1152–1161. [DOI] [PubMed] [Google Scholar]
- Bakris GL, Fonseca V, Katholi RE, McGill JB, Messerli FH, Phillips RA, Raskin P, Wright JT Jr., Oakes R, Lukas MA, Anderson KM, Bell DS & Investigators G. (2004). Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. JAMA 292, 2227–2236. [DOI] [PubMed] [Google Scholar]
- Barnes VA, Pendergrast RA, Harshfield GA & Treiber FA. (2008). Impact of breathing awareness meditation on ambulatory blood pressure and sodium handling in prehypertensive African American adolescents. Ethn Dis 18, 1–5. [PMC free article] [PubMed] [Google Scholar]
- Burton AR, Fazalbhoy A & Macefield VG. (2016). Sympathetic Responses to Noxious Stimulation of Muscle and Skin. Front Neurol 7, 109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chida Y & Steptoe A. (2010). Greater cardiovascular responses to laboratory mental stress are associated with poor subsequent cardiovascular risk status: a meta-analysis of prospective evidence. Hypertension 55, 1026–1032. [DOI] [PubMed] [Google Scholar]
- Creswell JD & Lindsay EK. (2014). How Does Mindfulness Training Affect Health? A Mindfulness Stress Buffering Account. Current Directions in Psychological Science 23, 401–407. [Google Scholar]
- Creswell JD, Pacilio LE, Lindsay EK & Brown KW. (2014). Brief mindfulness meditation training alters psychological and neuroendocrine responses to social evaluative stress. Psychoneuroendocrinology 44, 1–12. [DOI] [PubMed] [Google Scholar]
- Creswell JD, Way BM, Eisenberger NI & Lieberman MD. (2007). Neural correlates of dispositional mindfulness during affect labeling. Psychosom Med 69, 560–565. [DOI] [PubMed] [Google Scholar]
- Curiati JA, Bocchi E, Freire JO, Arantes AC, Braga M, Garcia Y, Guimaraes G & Fo WJ. (2005). Meditation reduces sympathetic activation and improves the quality of life in elderly patients with optimally treated heart failure: a prospective randomized study. J Altern Complement Med 11, 465–472. [DOI] [PubMed] [Google Scholar]
- Dampney RAL. (2017). Resetting of the Baroreflex Control of Sympathetic Vasomotor Activity during Natural Behaviors: Description and Conceptual Model of Central Mechanisms. Front Neurosci 11, 461. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ditto B, Eclache M & Goldman N. (2006). Short-term autonomic and cardiovascular effects of mindfulness body scan meditation. Ann Behav Med 32, 227–234. [DOI] [PubMed] [Google Scholar]
- Dutcher JM, Boyle CC, Eisenberger NI, Cole SW & Bower JE. (2021). Neural responses to threat and reward and changes in inflammation following a mindfulness intervention. Psychoneuroendocrinology 125, 105114. [DOI] [PubMed] [Google Scholar]
- Eisendrath SJ, Gillung E, Delucchi KL, Segal ZV, Nelson JC, McInnes LA, Mathalon DH & Feldman MD. (2016). A Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy for Treatment-Resistant Depression. Psychother Psychosom 85, 99–110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Eisendrath SJ, Gillung EP, Delucchi KL, Chartier M, Mathalon DH, Sullivan JC, Segal ZV & Feldman MD. (2014). Mindfulness-based cognitive therapy (MBCT) versus the health-enhancement program (HEP) for adults with treatment-resistant depression: a randomized control trial study protocol. BMC Complement Altern Med 14, 95. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fonkoue IT, Hu Y, Jones T, Vemulapalli M, Sprick JD, Rothbaum B & Park J. (2020). Eight weeks of device-guided slow breathing decreases sympathetic nervous reactivity to stress in posttraumatic stress disorder. Am J Physiol Regul Integr Comp Physiol 319, R466–R475. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gallagher KM, Fadel PJ, Smith SA, Stromstad M, Ide K, Secher NH & Raven PB. (2006). The interaction of central command and the exercise pressor reflex in mediating baroreflex resetting during exercise in humans. Exp Physiol 91, 79–87. [DOI] [PubMed] [Google Scholar]
- Garland EL, Farb NA, Goldin P & Fredrickson BL. (2015). Mindfulness Broadens Awareness and Builds Eudaimonic Meaning: A Process Model of Mindful Positive Emotion Regulation. Psychol Inq 26, 293–314. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Go AS, Chertow GM, Fan D, McCulloch CE & Hsu CY. (2004). Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351, 1296–1305. [DOI] [PubMed] [Google Scholar]
- Goldin PR & Gross JJ. (2010). Effects of mindfulness-based stress reduction (MBSR) on emotion regulation in social anxiety disorder. Emotion 10, 83–91. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Goldstein CM, Josephson R, Xie S & Hughes JW. (2012). Current perspectives on the use of meditation to reduce blood pressure. Int J Hypertens 2012, 578397. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Grassi G, Quarti-Trevano F, Seravalle G, Arenare F, Volpe M, Furiani S, Dell'Oro R & Mancia G. (2011). Early sympathetic activation in the initial clinical stages of chronic renal failure. Hypertension 57, 846–851. [DOI] [PubMed] [Google Scholar]
- Herman JP, Figueiredo H, Mueller NK, Ulrich-Lai Y, Ostrander MM, Choi DC & Cullinan WE. (2003). Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front Neuroendocrinol 24, 151–180. [DOI] [PubMed] [Google Scholar]
- Herzog CA, Asinger RW, Berger AK, Charytan DM, Diez J, Hart RG, Eckardt KU, Kasiske BL, McCullough PA, Passman RS, DeLoach SS, Pun PH & Ritz E. (2011). Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 80, 572–586. [DOI] [PubMed] [Google Scholar]
- Hoge EA, Bui E, Marques L, Metcalf CA, Morris LK, Robinaugh DJ, Worthington JJ, Pollack MH & Simon NM. (2013). Randomized controlled trial of mindfulness meditation for generalized anxiety disorder: effects on anxiety and stress reactivity. J Clin Psychiatry 74, 786–792. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hoge EA, Bui E, Palitz SA, Schwarz NR, Owens ME, Johnston JM, Pollack MH & Simon NM. (2018). The effect of mindfulness meditation training on biological acute stress responses in generalized anxiety disorder. Psychiatry Res 262, 328–332. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Holzel BK, Hoge EA, Greve DN, Gard T, Creswell JD, Brown KW, Barrett LF, Schwartz C, Vaitl D & Lazar SW. (2013). Neural mechanisms of symptom improvements in generalized anxiety disorder following mindfulness training. Neuroimage Clin 2, 448–458. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hundemer GL, Knoll GA, Petrcich W, Hiremath S, Ruzicka M, Burns KD, Edwards C, Bugeja A, Rhodes E & Sood MM. (2021). Kidney, Cardiac, and Safety Outcomes Associated With alpha-Blockers in Patients With CKD: A Population-Based Cohort Study. Am J Kidney Dis 77, 178–189 e171. [DOI] [PubMed] [Google Scholar]
- Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, Crews DC, Doria A, Estrella MM, Froissart M, Grams ME, Greene T, Grubb A, Gudnason V, Gutiérrez OM, Kalil R, Karger AB, Mauer M, Navis G, Nelson RG, Poggio ED, Rodby R, Rossing P, Rule AD, Selvin E, Seegmiller JC, Shlipak MG, Torres VE, Yang W, Ballew SH, Couture SJ, Powe NR & Levey AS. (2021). New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. N Engl J Med 385, 1737–1749. [DOI] [PMC free article] [PubMed] [Google Scholar]
- James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC Jr., Svetkey LP, Taler SJ, Townsend RR, Wright JT Jr., Narva AS & Ortiz E. (2014). 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311, 507–520. [DOI] [PubMed] [Google Scholar]
- Jeleazcov C, Krajinovic L, Munster T, Birkholz T, Fried R, Schuttler J & Fechner J. (2010). Precision and accuracy of a new device (CNAPTM) for continuous non-invasive arterial pressure monitoring: assessment during general anaesthesia. Br J Anaesth 105, 264–272. [DOI] [PubMed] [Google Scholar]
- Kienbaum P, Karlssonn T, Sverrisdottir YB, Elam M & Wallin BG. (2001). Two sites for modulation of human sympathetic activity by arterial baroreceptors? J Physiol 531, 861–869. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Klein IH, Ligtenberg G, Neumann J, Oey PL, Koomans HA & Blankestijn PJ. (2003). Sympathetic nerve activity is inappropriately increased in chronic renal disease. J Am Soc Nephrol 14, 3239–3244. [DOI] [PubMed] [Google Scholar]
- Kroes ADA & Finley JR. (2023). Demystifying omega squared: Practical guidance for effect size in common analysis of variance designs. Psychol Methods. [DOI] [PubMed] [Google Scholar]
- Lakens D. (2013). Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs. Front Psychol 4, 863. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lakhan SE & Schofield KL. (2013). Mindfulness-based therapies in the treatment of somatization disorders: a systematic review and meta-analysis. PLoS One 8, e71834. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lee EKP, Yeung NCY, Xu Z, Zhang D, Yu CP & Wong SYS. (2020). Effect and Acceptability of Mindfulness-Based Stress Reduction Program on Patients With Elevated Blood Pressure or Hypertension: A Meta-Analysis of Randomized Controlled Trials. Hypertension 76, 1992–2001. [DOI] [PubMed] [Google Scholar]
- Lengacher CA, Kip KE, Barta M, Post-White J, Jacobsen PB, Groer M, Lehman B, Moscoso MS, Kadel R, Le N, Loftus L, Stevens CA, Malafa MP & Shelton MM. (2012). A pilot study evaluating the effect of mindfulness-based stress reduction on psychological status, physical status, salivary cortisol, and interleukin-6 among advanced-stage cancer patients and their caregivers. J Holist Nurs 30, 170–185. [DOI] [PubMed] [Google Scholar]
- Lengacher CA, Shelton MM, Reich RR, Barta MK, Johnson-Mallard V, Moscoso MS, Paterson C, Ramesar S, Budhrani P, Carranza I, Lucas J, Jacobsen PB, Goodman MJ & Kip KE. (2014). Mindfulness based stress reduction (MBSR(BC)) in breast cancer: evaluating fear of recurrence (FOR) as a mediator of psychological and physical symptoms in a randomized control trial (RCT). J Behav Med 37, 185–195. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lindsay EK, Young S, Smyth JM, Brown KW & Creswell JD. (2018). Acceptance lowers stress reactivity: Dismantling mindfulness training in a randomized controlled trial. Psychoneuroendocrinology 87, 63–73. [DOI] [PubMed] [Google Scholar]
- Loucks EB, Nardi WR, Gutman R, Kronish IM, Saadeh FB, Li Y, Wentz AE, Webb J, Vago DR, Harrison A & Britton WB. (2019). Mindfulness-Based Blood Pressure Reduction (MB-BP): Stage 1 single-arm clinical trial. PLoS One 14, e0223095. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Loucks EB, Schuman-Olivier Z, Britton WB, Fresco DM, Desbordes G, Brewer JA & Fulwiler C. (2015). Mindfulness and Cardiovascular Disease Risk: State of the Evidence, Plausible Mechanisms, and Theoretical Framework. Curr Cardiol Rep 17, 112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MacCoon DG, Imel ZE, Rosenkranz MA, Sheftel JG, Weng HY, Sullivan JC, Bonus KA, Stoney CM, Salomons TV, Davidson RJ & Lutz A. (2012). The validation of an active control intervention for Mindfulness Based Stress Reduction (MBSR). Behav Res Ther 50, 3–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Manikonda JP, Stork S, Togel S, Lobmuller A, Grunberg I, Bedel S, Schardt F, Angermann CE, Jahns R & Voelker W. (2008). Contemplative meditation reduces ambulatory blood pressure and stress-induced hypertension: a randomized pilot trial. J Hum Hypertens 22, 138–140. [DOI] [PubMed] [Google Scholar]
- Mano T, Iwase S & Toma S. (2006). Microneurography as a tool in clinical neurophysiology to investigate peripheral neural traffic in humans. Clin Neurophysiol 117, 2357–2384. [DOI] [PubMed] [Google Scholar]
- Mark AL, Victor RG, Nerhed C & Wallin BG. (1985). Microneurographic studies of the mechanisms of sympathetic nerve responses to static exercise in humans. Circ Res 57, 461–469. [DOI] [PubMed] [Google Scholar]
- Modinos G, Ormel J & Aleman A. (2010). Individual differences in dispositional mindfulness and brain activity involved in reappraisal of emotion. Soc Cogn Affect Neurosci 5, 369–377. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Neumann J, Ligtenberg G, Klein II, Koomans HA & Blankestijn PJ. (2004). Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatment. Kidney Int 65, 1568–1576. [DOI] [PubMed] [Google Scholar]
- Nijjar PS, Puppala VK, Dickinson O, Duval S, Duprez D, Kreitzer MJ & Benditt DG. (2014). Modulation of the autonomic nervous system assessed through heart rate variability by a mindfulness based stress reduction program. Int J Cardiol 177, 557–559. [DOI] [PubMed] [Google Scholar]
- Nyklicek I, Mommersteeg PM, Van Beugen S, Ramakers C & Van Boxtel GJ. (2013). Mindfulness-based stress reduction and physiological activity during acute stress: a randomized controlled trial. Health Psychol 32, 1110–1113. [DOI] [PubMed] [Google Scholar]
- Ohlstein EH, Brooks DP, Feuerstein GZ & Ruffolo RR Jr. (1997). Inhibition of sympathetic outflow by the angiotensin II receptor antagonist, eprosartan, but not by losartan, valsartan or irbesartan: relationship to differences in prejunctional angiotensin II receptor blockade. Pharmacology 55, 244–251. [DOI] [PubMed] [Google Scholar]
- Park J, Lyles RH & Bauer-Wu S. (2014). Mindfulness meditation lowers muscle sympathetic nerve activity and blood pressure in African-American males with chronic kidney disease. Am J Physiol Regul Integr Comp Physiol 307, R93–R101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Park J, Marvar PJ, Liao P, Kankam ML, Norrholm SD, Downey RM, McCullough SA, Le NA & Rothbaum BO. (2017). Baroreflex dysfunction and augmented sympathetic nerve responses during mental stress in veterans with post-traumatic stress disorder. J Physiol 595, 4893–4908. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Park J, Quyyumi AA & Middlekauff HR. (2013). Exercise pressor response and arterial baroreflex unloading during exercise in chronic kidney disease. J Appl Physiol (1985) 114, 538–549. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sabino-Carvalho JL, Jeong J, Sprick J, DaCosta D, Nardone M & Park J. (2023). Augmented resting beat-to-beat blood pressure variability in patients with chronic kidney disease. Clin Auton Res 33, 705–714. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sabino-Carvalho JL, Mekonnen E, Zanuzzi M, Li S, Cui X & Park J. (2024). Impaired neurocirculatory control in chronic kidney disease: New evidence for blunted sympathetic baroreflex and reduced sympathetic transduction. Function (Oxf). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schultz MG, Otahal P, Cleland VJ, Blizzard L, Marwick TH & Sharman JE. (2013). Exercise-induced hypertension, cardiovascular events, and mortality in patients undergoing exercise stress testing: a systematic review and meta-analysis. Am J Hypertens 26, 357–366. [DOI] [PubMed] [Google Scholar]
- Scott-Sheldon LAJ, Gathright EC, Donahue ML, Balletto B, Feulner MM, DeCosta J, Cruess DG, Wing RR, Carey MP & Salmoirago-Blotcher E. (2020). Mindfulness-Based Interventions for Adults with Cardiovascular Disease: A Systematic Review and Meta-Analysis. Ann Behav Med 54, 67–73. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shapiro SL, Carlson LE, Astin JA & Freedman B. (2006). Mechanisms of mindfulness. J Clin Psychol 62, 373–386. [DOI] [PubMed] [Google Scholar]
- Smith SA, Mitchell JH & Garry MG. (2006). The mammalian exercise pressor reflex in health and disease. Exp Physiol 91, 89–102. [DOI] [PubMed] [Google Scholar]
- Taren AA, Gianaros PJ, Greco CM, Lindsay EK, Fairgrieve A, Brown KW, Rosen RK, Ferris JL, Julson E, Marsland AL, Bursley JK, Ramsburg J & Creswell JD. (2015). Mindfulness meditation training alters stress-related amygdala resting state functional connectivity: a randomized controlled trial. Soc Cogn Affect Neurosci 10, 1758–1768. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tomiyama H & Yamashina A. (2014). Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease. Int J Hypertens 2014, 919256. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ulrich-Lai YM & Herman JP. (2009). Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci 10, 397–409. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Victor RG, Leimbach WN Jr., Seals DR, Wallin BG & Mark AL. (1987). Effects of the cold pressor test on muscle sympathetic nerve activity in humans. Hypertension 9, 429–436. [DOI] [PubMed] [Google Scholar]
- Vonend O, Marsalek P, Russ H, Wulkow R, Oberhauser V & Rump LC. (2003). Moxonidine treatment of hypertensive patients with advanced renal failure. J Hypertens 21, 1709–1717. [DOI] [PubMed] [Google Scholar]
- Wallin BG & Fagius J. (1988). Peripheral sympathetic neural activity in conscious humans. Annu Rev Physiol 50, 565–576. [DOI] [PubMed] [Google Scholar]
- Wang SJ, Chang YC, Hu WY, Chang YM & Lo C. (2022). The Comparative Effect of Reduced Mindfulness-Based Stress on Heart Rate Variability among Patients with Breast Cancer. Int J Environ Res Public Health 19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weiss SA, Blumenthal RS, Sharrett AR, Redberg RF & Mora S. (2010). Exercise blood pressure and future cardiovascular death in asymptomatic individuals. Circulation 121, 2109–2116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Whelton PK, Carey RM, Aronow WS, Casey DE Jr., Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC Jr., Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA Sr, Williamson JD & Wright JT Jr.. (2018). 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 71, e127–e248. [DOI] [PubMed] [Google Scholar]
- Younge JO, Gotink RA, Baena CP, Roos-Hesselink JW & Hunink MG. (2015). Mind-body practices for patients with cardiac disease: a systematic review and meta-analysis. Eur J Prev Cardiol 22, 1385–1398. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supplemental Figure 1. Mean and Individual Reactivity in Muscle Sympathetic Nervous Activity (MSNA) Burst Frequency (A, B), MSNA Burst Incidence (C, D), Mean Arterial Blood Pressure (MAP) (E, F) and Heart Rate (HR) (G, H) during each minute of Mental Arithmetic from baseline (0 wk) to post-intervention (8 wk) in patients with chronic kidney disease randomized to Mindfulness-Based Stress Reduction (MBSR; N=17). Closed circles represent the means and standard deviations at the Minute.
P-values represent significant levels of within-group comparisons on the changes over 3 minutes by repeated ANOVA tests.
* denotes statistically significant within-group difference from Minute 0 by LSD post-hoc tests.
# denotes statistically significant within-group difference from Minute 1 by LSD post-hoc tests.
Supplemental Figure 2. Mean and Individual Reactivity in Muscle Sympathetic Nervous Activity (MSNA) Burst Frequency (A, B), MSNA Burst Incidence (C, D), Mean Arterial Blood Pressure (MAP) (E, F) and Heart Rate (HR) (G, H) during each minute of Mental Arithmetic from baseline (0 wk) to post-intervention (8 wk) in patients with chronic kidney disease randomized to Health Enhancement Program (HEP; N=12). Closed circles represent the means and standard deviations at the Minute.
P-values represent significant levels of within-group comparisons on the changes over 3 minutes by repeated ANOVA tests.
* denotes statistically significant within-group difference from Minute 0 by LSD post-hoc tests.
# denotes statistically significant within-group difference from Minute 1 by LSD post-hoc tests.
Data Availability Statement
All data supporting the results of the present study are reported in the manuscript.
